- 30Med, a pioneering B2B healthtech startup in Egypt, recently secured pre-seed funding from undisclosed angel investors, marking a significant milestone in its journey to revolutionize medical education.
- Led by visionary entrepreneur Dr. Ayman Ragab, 30Med aims to bridge the gap between pharmaceutical companies and physicians through interactive videos and conference events, offering a novel approach to continuous learning within the medical community.
- With strategic partnerships with leading pharmaceutical companies and a rapidly growing user base of physicians, 30Med is poised to make a substantial impact on medical education, not only in Egypt but potentially on a global scale, driving innovation and excellence in healthcare delivery.
30Med, a B2B healthtech startup based in Egypt, has recently secured pre-seed funding from undisclosed angel investors. Founded in 2023 by Ayman Ragab, the company aims to bridge the gap between pharmaceutical companies and physicians by offering interactive videos and conference events that showcase new medicines and support continuous learning within the medical community.
Led by visionary entrepreneur Dr. Ayman Ragab, 30Med is set to revolutionize the landscape of medical education. The platform leverages innovative approaches to engage physicians and enhance their knowledge base. By facilitating interactions between healthcare professionals and pharmaceutical companies, 30Med is paving the way for a more informed and collaborative healthcare ecosystem.
The pre-seed funding marks a significant milestone for 30Med, signaling confidence in its vision and potential. With this investment, the company is well-positioned to further develop its platform and extend its reach within the medical community. This funding injection will enable 30Med to enhance its offerings and drive impactful advancements in medical education and healthcare delivery.
30Med’s success in securing pre-seed funding underscores its commitment to transforming healthcare through technology-driven solutions. With the support of its investors, the company is poised to make a meaningful impact on the way physicians engage with medical education and ultimately contribute to improved patient care.
Doctor Ayman Ragab, CEO of 30Med expressed immense joy as he announced the successful completion of their pre-seed funding round. This achievement not only validates their mission but also paves the way for accelerating efforts in transforming medical education. With a substantial user base already onboard, consisting of doctors keen on staying updated with the latest medical advancements, 30Med has garnered remarkable traction within the medical community.
Moreover, the platform’s strategic partnerships with leading pharmaceutical companies in Egypt highlight its commitment to reshaping medical education. Through interactive videos and conference events, 30Med provides a seamless avenue for these companies to showcase new medicines, revolutionizing the dissemination and accessibility of medical information.
As 30Med continues to expand, it remains dedicated to empowering physicians, enabling them to enhance their expertise and stay ahead in the ever-evolving healthcare landscape. Dr. Ragab emphasized the significance of these achievements, noting how they align with 30Med’s overarching goal of facilitating continuous learning and advancement within the medical field.
With this successful funding round and growing partnerships, 30Med is poised to make a significant impact on medical education, not just in Egypt but potentially on a global scale. Dr. Ragab expressed gratitude to all those who have supported 30Med’s journey thus far and reiterated the team’s unwavering commitment to driving innovation and excellence in medical education.
